Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹157 Cr₹179 Cr₹174 Cr₹82 Cr₹123 Cr

What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES is ₹157 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹157 Cr
Mar2023₹179 Cr
Mar2022₹174 Cr
Mar2021₹82 Cr
Mar2020₹123 Cr

How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹157 Cr
-12.38
Mar2023 ₹179 Cr
2.88
Mar2022 ₹174 Cr
111.41
Mar2021 ₹82 Cr
-33.07
Mar2020 ₹123 Cr -

Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,323.9 Cr 5.3% 7.4% -27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,717.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 3.1% 9.8% -7.6% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

5.3%

7.4%

-27.5%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses